This HTML5 document contains 123 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n9http://dx.doi.org/10.1080/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q53447963
rdf:type
wikibase:Item
schema:description
επιστημονικό άρθρο 1997年学术文章 مقالة علمية نشرت في يناير 1997 artigo científico videnskabelig artikel article científic bài báo khoa học article scientific naučni članak 1997年学术文章 1997年の論文 scientific article published in January 1997 scientific article published in January 1997 tieteellinen artikkeli мақолаи илмӣ 1997年学术文章 artikulong pang-agham wissenschaftlicher Artikel 1997年學術文章 научна статия articol științific teaduslik artikkel מאמר מדעי artikel ilmiah vetenskaplig artikel artículo científico publicado en 1997 vitskapeleg artikkel 1997年学术文章 tudományos cikk জানুয়ারি ১৯৯৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artigo científico wetenschappelijk artikel บทความทางวิทยาศาสตร์ 1997년 논문 научни чланак article scientifique наукова стаття, опублікована в січні 1997 1997年學術文章 scienca artikolo bilimsel makale vědecký článek scientific article published in January 1997 1997年學術文章 1997年学术文章 სამეცნიერო სტატია научная статья vitenskapelig artikkel articolo scientifico artigo científico научни чланак 1997年学术文章 vedecký článok artículu científicu artykuł naukowy 1997 nî lūn-bûn artikull shkencor 1997年學術文章 1997年學術文章
p:P577
wds:Q53447963-993BED87-C3D1-4AD5-B09C-CA1D626B4E84
wdt:P577
1997-01-01T00:00:00Z
p:P2860
wds:Q53447963-B0A5C680-5EF8-4C6F-B90E-1A9292E6C806 wds:Q53447963-B13F3EA8-C541-4B58-9835-0500B619083B wds:Q53447963-C0DE7E62-0007-4AF4-8244-937F1355E387 wds:Q53447963-9A73A086-8E84-41D2-8E42-84AFB38B0F10 wds:Q53447963-9EBB3C8E-23D6-41E3-A1E6-5922EB46F606 wds:Q53447963-182110C0-8DD7-48F6-A4FA-496984FFAB4E wds:Q53447963-6811D873-ECDE-4976-999E-4C3966A87D1B wds:Q53447963-1EEE8B41-5AB2-4169-BE7E-D1B32278FE5F wds:Q53447963-37BA4FA1-08B8-4DE8-AE4F-5664FFFB49C0 wds:Q53447963-3EE6F3FC-B756-4661-B829-C4EF1FBFA469 wds:Q53447963-0201C704-623B-4CA0-8DC0-29B7200B54C4 wds:Q53447963-6088563A-3CEE-48C6-BBEA-BC9B7D928764 wds:Q53447963-08186436-246F-4AAE-941E-BEA71A181F8B
wdt:P2860
wd:Q38509877 wd:Q42492662 wd:Q37943870 wd:Q51611260 wd:Q36685332 wd:Q42280734 wd:Q52461467 wd:Q53485510 wd:Q34328024 wd:Q24685874 wd:Q53497795 wd:Q34907003 wd:Q40599712
p:P2093
wds:Q53447963-1A674E87-F77D-4CA1-AA2D-A0991028745A wds:Q53447963-8185E417-BA9A-49B9-A649-0BCF85CF27BC wds:Q53447963-683BC763-D76B-4FE9-AA16-EED053A97A02 wds:Q53447963-E5C4EEDD-B875-4BA6-8C26-116E0F119D74
wdt:P2093
Sigounas G Hooker J Steiner M Anagnostou A
rdfs:label
S-allylmercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia, breast, and prostate cancer cell lines. S-allylmercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia, breast, and prostate cancer cell lines.
skos:prefLabel
S-allylmercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia, breast, and prostate cancer cell lines. S-allylmercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia, breast, and prostate cancer cell lines.
schema:name
S-allylmercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia, breast, and prostate cancer cell lines. S-allylmercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia, breast, and prostate cancer cell lines.
p:P1476
wds:Q53447963-D5E26DBA-AAB9-4DB6-9C2A-CC8AC4DB1BEE
wdt:P1476
S-allylmercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia, breast, and prostate cancer cell lines.
p:P304
wds:Q53447963-913E4F7A-AB8E-4A0D-B30D-179597E6DA2B
wdt:P304
186-191
p:P31
wds:Q53447963-E7462A85-8DD7-48C7-A94F-EC557E672A2E
wdt:P31
wd:Q13442814
p:P921
wds:Q53447963-C8704A73-D3E2-47AB-8298-91532A5B05E2 wds:Q53447963-BD64FABB-00E9-446A-B59D-97B0010B693B
wdt:P921
wd:Q181257 wd:Q3843804
p:P698
wds:Q53447963-DABB5353-83BB-4D7E-A983-E8DFDF0EB52D
wdtn:P698
n11:9121948
wdt:P698
9121948
p:P1433
wds:Q53447963-C39A6614-2E65-424B-8474-601FC2156EF9
wdt:P1433
wd:Q7070508
p:P433
wds:Q53447963-62A64903-6D98-4342-AFA6-3FCB92797E10
p:P478
wds:Q53447963-9A4DBEB9-1970-4ACF-A247-D0602C12866E
wdt:P433
2
wdt:P478
27
p:P356
wds:Q53447963-22229FE5-AA41-44A0-B092-6589F366F7CA
wdtn:P356
n9:01635589709514523
wdt:P356
10.1080/01635589709514523